nonprofit logo

Addario Lung Cancer Medical Institute

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 261721868 ✦ San carlos, CA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Addario Lung Cancer Medical Institute?

The Addario Lung Cancer Medical Institute (ALCMI) is a patient-driven, California-based research organization, established in 2008. Its primary aim is to expedite and enhance the discovery, development, and delivery of innovative treatment options for lung cancer patients, transforming the disease into a manageable chronic condition. By partnering with the Go2 for Lung Cancer Foundation, ALCMI collects and analyzes tissue and blood samples to facilitate the creation of personalized therapies. Furthermore, the institute operates as a unified consortium with shared resources and centralized scientific planning, fostering collaborative research and advancements in the field of lung cancer treatment.


Official website here: www.alcmi.net

What are the reviews and ratings of this charity?

Charity Navigator Rating: 96% (Four-Star out of Four Star Rating)

The Addario Lung Cancer Medical Institute (ALCMI) has achieved an impressive four-star rating, reflecting its strong performance in accountability and finance. The organization scored 96% overall, indicating high standards in financial management and transparency. Key strengths include a fully independent board and a robust program expense ratio of 87.47%, showcasing its commitment to utilizing the majority of resources for its mission.

User feedback consistently highlights the organization's dedication to improving lung cancer outcomes. Many reviewers express admiration for ALCMI's impactful research and patient-centered initiatives, emphasizing the staff's compassion and commitment. Professionals in the field recognize ALCMI as a pioneering entity in collaborative lung cancer research, with several reviews praising its innovative approach and the significant potential for improving patient experiences and survivorship.

Overall, ALCMI is regarded as a leader in lung cancer advocacy and research, with a solid structure that supports its mission. While the data indicates strong financial practices and positive reviews from stakeholders, ongoing engagement with donors and the community may further enhance its visibility and impact in the fight against lung cancer.


This AI summary has been generated from information found on Charity Navigator and Great Nonprofits.

Is Addario Lung Cancer Medical Institute legitimate?

Addario Lung Cancer Medical Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Addario Lung Cancer Medical Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $212,253
Professional Fundraising Fees: $0
Other Salaries and Wages: $99,004

For more financial information, click here


Official website here: www.alcmi.net

What is the mission statement of Addario Lung Cancer Medical Institute?

The Addario Lung Cancer Medical Institute (ALCMI) is committed to expediting and enhancing the discovery, development, and delivery of innovative treatment options for lung cancer patients. As a patient-driven, patient-centric research consortium, ALCMI aims to transform lung cancer into a manageable chronic condition. Established in 2008, the institute collaborates with the Go2 for Lung Cancer Foundation and other partners to gather and analyze tissue and blood samples, facilitating the development of personalized therapies. ALCMI operates as a comprehensively contracted consortium, leveraging shared infrastructure, standardized contracts, data systems, and biorepositories to foster scientific collaboration and planning.


Official website here: www.alcmi.net

Who is the CEO of Addario Lung Cancer Medical Institute?

Tony Addario is the Senior Dir. Clinical Operations of Addario Lung Cancer Medical Institute. The CEO's salary of Addario Lung Cancer Medical Institute is $0 and their total compensation is $0.


Official website here: www.alcmi.net

What is the revenue of Addario Lung Cancer Medical Institute?

Addario Lung Cancer Medical Institute's revenue in 2022 was $1,061,978.


Official website here: www.alcmi.net

Who are the executives of Addario Lung Cancer Medical Institute and what are their salaries?

The average compensation at Addario Lung Cancer Medical Institute during 2022 was $311,257. There is 1 employee at Addario Lung Cancer Medical Institute.


Here are 7 key members and their salaries (Addario Lung Cancer Medical Institute's CEO's salary is $0 and their total compensation is $0):


Richard Erwin (Senior Dir. Clinical Operations)
  • Compensation: $202,470
  • Related: $0
  • Other: $8,967
Tony Addario Chair (Ceo)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sam Bain Treasurer (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Bonnie Addario (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Bruce Gellman (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Pankaj Patel (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Ignacio Del Rio (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.alcmi.net

Where can I find the form 990 for Addario Lung Cancer Medical Institute?

Addario Lung Cancer Medical Institute's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.alcmi.net

Learn more at the official website: www.alcmi.net

Mission Statement of Addario Lung Cancer Medical Institute

The Addario Lung Cancer Medical Institute, abbreviated as ALCMI, is an organization dedicated to driving and expediting the exploration, development, and availability of improved treatment options for individuals battling lung cancer. This patient-centric research consortium aims to transform lung cancer from a life-threatening disease into a manageable chronic condition. Established in 2008, ALCMI operates as a partner organization with Go2 for Lung Cancer Foundation (Wash DC). One of its primary objectives is to gather and analyze tissue and blood samples, which are crucial for research and the creation of personalized (and more effective) therapies. ALCMI is also a consolidated consortium, characterized by shared infrastructures, standardized contracts, data systems, and biorepositories. The organization's centralized scientific planning further facilitates its mission to revolutionize the treatment landscape for lung cancer patients.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The Addario Lung Cancer Medical Institute (ALCMI) has made a significant impact in the field of lung cancer research and treatment. Founded in 2008, ALCMI is at the forefront of efforts to transform lung cancer into a manageable chronic disease. By focusing on the collection and analysis of tissue and blood samples, the institute facilitates the development of personalized therapies tailored to the specific needs of individual patients.

As a comprehensive research consortium, ALCMI fosters collaboration among various stakeholders through standardized contracts, data systems, and biorepositories. This coordinated approach enhances the efficiency of scientific planning and research initiatives aimed at discovering, developing, and delivering innovative treatment options. The institute's patient-centered philosophy ensures that research efforts are aligned with the realities faced by those living with lung cancer.

Working in partnership with organizations like Go2 for Lung Cancer Foundation, ALCMI plays a critical role in advancing lung cancer research, ultimately seeking to improve outcomes for patients and provide hope through more effective therapeutic options.




This information is meant to be a general summary of Addario Lung Cancer Medical Institute. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$1,061,978 (2022)
Expenses
$987,672 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $90
  • Program Service Revenue: $438,979
  • Gross Receipts: $1,061,978

Assets and Liabilities:

  • Total Assets: $1,003,534
  • Total Liabilities: $71,426
  • Net Assets: $932,108

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

Fees for Services

Revenue

$438,979

Organization Details

Founding Year

2008

Principal Officer

Tony Addario

Main Address

1100 Industrial Road Suite 1, San Carlos, CA, 94070

NTEE Category

Code: H45 - Medical research

If you are a representative of Addario Lung Cancer Medical Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.